Driving down Leavenworth or Dodge streets, the average person might see the Fred & Pamela Buffett Cancer Center, located on the UNMC/Nebraska Medicine campus, as something of a museum because of its notable artwork and architecture.
It is also vital to note the advanced medical technology used to detect and treat cancer at UNMC/Nebraska Medicine.
Mihaela Girbacica is a registered nurse who works directly with cancer patients every day and depends on smoothly functioning tech to do her job.
“I sit next to a patient one-on-one for their entire treatment,” Girbacica says. “We become like a family. I bond with them, I know what makes them comfortable and [feel] taken care of when they are with us, and when things go well, I’m so happy to be there for that, too.”
Having a support network (or favorite nurse) is a key facet to fighting the cancer battle, but finding and targeting cancerous tumors is at the forefront of fighting the war.
Dr. Chad LaGrange, a urologist with the cancer center, has helped to revolutionize the discovery of prostate cancers by using an MRI Ultrasound Fusion Biopsy. Essentially, this procedure, which takes place at Nebraska Medicine’s Lauritzen Outpatient Center, blends the technology of an ultrasound and MRI by combining one image with another, overlaid, image to fuse into a 3-D view.
LaGrange says this tool allows technicians to view a clearer image of the area they must work on to remove all of the cancer. The fusion biopsies also remove needless worry and unwarranted medical procedures if patients are not diagnosed with life-threatening cancers.
“It’s been a night-to-day difference,” LaGrange says. “Patients will come into our office to find out that their regular biopsies didn’t tell the whole story. Our equipment ensures that part of the major diagnosis doesn’t go missed.”
While this computer-aided detection has been used for mammography and breast cancer screenings for years, its assistance in prostate cancer detection has reimagined—and reimaged—the way doctors analyze potential deadly lesions.
From easily treatable small cancers to aggressive life-threatening cancers, the next step can often lead to radiation and chemotherapy treatment.
Dr. Charles Enke, chair of Radiation Oncology, regularly uses the department’s Varian True Beam Linear Accelerator, a radiation device that delivers treatment to patients 75 percent faster than any other previous piece of tech used at Nebraska Medicine.
“We’ve gotten up to seeing 115 patients in one day because of this much more elegant system,” Enke says. “The delivery time for this kind of treatment has decreased from 18 minutes to about three, meaning we have the ability to treat more patients with less machines.”
The Fred & Pamela Buffett Cancer Center is home to three of these machines, which Enke says has increased the speed and quality of most radiation plans. Treatment has transformed from a six-week plan to five simple treatments, maintaining a Nebraska Medicine culture of patient-centered care.
Enke also has the ability to work from home using the machine’s remote system. This makes room for peace, quiet, and well-rested research, resulting in an environment where work done in the office directly affects patients.
People often assume a cure for cancer will be a revelation; a singular miracle. However, that in-office work, albeit common and routine, is what will bring further knowledge to the professionals. Curing cancer is a daily goal, comprised of small and strong steps, increased technological advancements, and a medical team ready to work.
To learn more, visit nebraskamed.com.
This article was printed in the August/September 2018 edition of B2B.